Stock Track | Nuvation Bio Plunges 14.04% in Pre-market Trading on Quarterly Earnings Miss

Stock Track03-03 18:22

Nuvation Bio Inc. (NUVB) shares plummeted 14.04% in pre-market trading on Tuesday. The sharp decline follows the biotechnology company's recent fourth-quarter earnings report.

The company reported a quarterly loss of $0.11 per share, which missed the analyst consensus estimate of a $0.09 loss by 22.22%. This earnings miss appears to be the primary driver behind the negative investor sentiment, outweighing the company's quarterly sales of $41.87 million, which surpassed estimates.

Nuvation Bio's net loss for the quarter was reported at $36.6 million. The market's reaction highlights the sensitivity of biotech stocks to earnings performance relative to Wall Street expectations, particularly for companies in the commercial stage like Nuvation Bio.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment